Updated Jul 16, 2026
TOMSICEK MICHAEL JOHN has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.

Based on the SEC filing context provided (Acrivon Therapeutics, Inc., as of 2026-05-20), Michael John Tomsicek is listed as an insider associated with Acrivon Therapeutics. The available information from the context does not specify his exact role or title within the company. No additional widely public biographical details for this exact name are evident in the provided SEC context. Additional sources would be needed to confirm his current position, background, education, and career history.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ACRV | Acrivon Therapeutics, Inc. | A — Grant or award | 9.4K | $0.00 |
Based on the SEC filing context provided (Acrivon Therapeutics, Inc., as of 2026-05-20), Michael John Tomsicek is listed as an insider associated with Acrivon Therapeutics. The available information from the context does not specify his exact role or title within the company. No additional widely public biographical details for this exact name are evident in the provided SEC co…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live TOMSICEK MICHAEL JOHN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.